LeGoo Internal Vessel Occluder 2.5mL Product Number: 10-0250 LeGoo is a water-soluble, biocom...
FDA Device Recall #Z-2151-2013 — Class II — June 21, 2013
Recall Summary
| Recall Number | Z-2151-2013 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 21, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Genzyme Corporation, A Sanofi Company |
| Location | Woburn, MA |
| Product Type | Devices |
| Quantity | 331 units |
Product Description
LeGoo Internal Vessel Occluder 2.5mL Product Number: 10-0250 LeGoo is a water-soluble, biocompatible polymer with reverse thermo-sensitive properties allowing it to be injected as a soft viscoelastic gel that forms an elastic plug within the vessel. LeGoo is indicated for temporary endovascular occlusion of blood vessels up to 4 mm in diameter below the neck.
Reason for Recall
Product contains particulates (fibers)
Distribution Pattern
Worldwide Distribution - USA (nationwide) and internationally to Austria, Belgium, Canada, Denmark, Egypt. Europe, Finland, France, Germany, Hong Kong, Ireland, Italy, Netherlands, Poland, Saudi Arabia, Slovena, Spain, Sweden, Switzerland, The Netherlands, Turkey, and UK.
Lot / Code Information
All lot codes
Other Recalls from Genzyme Corporation, A Sanofi Company
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2142-2013 | Class II | LeGoo¿ Endovascular Occlusion Gel-0.5 mL LeGoo ... | Jun 21, 2013 |
| Z-2148-2013 | Class II | LeGoo Internal Vessel Occluder .25mL Produc... | Jun 21, 2013 |
| Z-2153-2013 | Class II | LeGoo Internal Vessel Occluder 10mL Product Nu... | Jun 21, 2013 |
| Z-2141-2013 | Class II | LeGoo¿ Endovascular Occlusion Gel-1.0 mL LeGoo ... | Jun 21, 2013 |
| Z-2152-2013 | Class II | LeGoo Internal Vessel Occluder 5mL Product Num... | Jun 21, 2013 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.